UNITED STATES

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended

March 31, 2009

 

Commission File Number

0-17187

 

LOGIC Devices Incorporated

(Exact name of registrant as specified in its charter)

 

California

94-2893789

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

 

1375 Geneva Drive, Sunnyvale, California 94089

(Address of principal executive offices)

(Zip Code)

 

(408) 542-5400

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes   X     No       

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act (Check One):

Large Accelerated Filer          Accelerated Filer          Non-Accelerated Filer  X 

 

Indicate by check whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes            No    X   

 

Indicate the number of shares outstanding of the issuer’s classes of common stock, as of the latest practicable date. On May 1, 2009, 6,814,438 shares of Common Stock, without par value, were issued and outstanding.

 



LOGIC Devices Incorporated

 

INDEX

 

 

 

 

 

Page

 

 

 

 

Number

Part I. Financial Information

 

 

Item 1. Financial Statements

 

 

 

Condensed Balance Sheets as of March 31, 2009 and September 30, 2008

3

 

 

Condensed Statements of Operations for the quarters ended March 31, 2009 and 2008

4

 

 

Condensed Statements of Operations for the six month periods ended March 31, 2009 and 2008

5

 

 

Condensed Statements of Cash Flows for the quarter  and six month periods ended March 31, 2009 and 2008

6

 

 

Notes to Condensed Financial Statements

7

 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

9

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

11

 

Item 4. Controls and Procedures

11

Part II. Other Information

 

 

Item 1. Legal Proceedings

11

 

Item 1A. Risk Factors

11

 

Item 4. Submission of Matters to a Vote of Security Holders

11

 

Item 6. Exhibits

12

Signatures

13

 



Part I – Financial Information

 

Item 1.  Financial Statements

 

Condensed Balance Sheets

 

 

 

 

 

March 31,

 

September 30,

 

 

 

 

2009

 

2008

 

 

 

 

(unaudited)

 

 

ASSETS

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

$

759,000 

 

$

312,400 

 

Investment in available-for-sale securities

– 

 

944,400 

 

Accounts receivable

367,400 

 

658,200 

 

Inventories

1,180,700 

 

1,424,700 

 

Prepaid expenses and other current assets

117,900 

 

136,800 

 

 

 

Total current assets

2,425,000 

 

3,476,500 

 

 

 

 

 

 

 

Property and equipment, net

832,800 

 

877,800 

Other assets, net

22,100 

 

22,100 

 

 

 

 

$

3,279,900 

 

$

4,376,400 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

$

82,100 

 

$

156,300 

 

Accrued payroll and vacation

105,100 

 

126,200 

 

Accrued commissions

12,200 

 

16,000 

 

Other accrued expenses

18,400 

 

16,000 

 

 

 

Total current liabilities

217,800 

 

314,500 

Deferred rent

35,000 

 

26,500 

 

 

 

Total liabilities

252,800 

 

341,000 

Commitments and contingencies

 

 

 

Shareholders' equity:

 

 

 

 

Preferred stock, no par value; 1,000,000 shares authorized;

 

 

 

 

 

5,000 designated as Series A, 0 shares issued and outstanding

– 

 

– 

 

 

70,000 designated as Series B, 0 shares issued and outstanding

– 

 

– 

 

Common stock, no par value; 10,000,000 shares authorized;

 

 

 

 

 

6,814,438  shares issued and outstanding

18,543,200 

 

18,543,200 

 

Additional paid-in capital

158,400 

 

155,600 

 

Comprehensive loss

– 

 

(30,600)

 

Accumulated deficit

(15,674,500)

 

(14,632,800)

 

 

 

Total shareholders' equity

3,027,100 

 

4,035,400 

 

 

 

 

$

3,279,900 

 

$

4,376,400 

 

 

 

See accompanying Notes to Condensed Financial Statements.



Condensed Statements of Operations

 

(unaudited)

 

 

 

 

 

For the quarters ended March 31,

 

 

 

 

2009 

 

2008 

Net revenues

$

555,700 

 

$

965,300 

Cost of revenues

278,000 

 

1,015,000 

 

 

 

Gross margin

277,700 

 

(49,700)

Operating expenses:

 

 

 

 

Research and development

308,400 

 

362,200 

 

Selling, general and administrative

386,700 

 

396,800 

 

 

Total operating expenses

695,100 

 

759,000 

 

 

 

Operating loss

(417,400)

 

(808,700)

Other income and expense, net

 

 

 

 

Interest income

1,800 

 

17,000 

 

Interest expense

(200)

 

– 

 

Other expense

(4,100)

 

– 

 

 

Other income and expense, net

(2,500)

 

17,000 

 

 

 

Loss before provision for income taxes

(419,900)

 

(791,700)

Provision for income taxes

900 

 

– 

 

 

 

Net loss

$

(420,800)

 

$

(791,700)

Basic and diluted loss per common share

$

(0.06)

 

$

(0.12)

Basic and diluted weighted average common shares outstanding

6,814,438 

 

6,814,438 

 

 

 

See accompanying Notes to Condensed Financial Statements.

 



Condensed Statements of Operations

 

(unaudited)

 

 

 

 

 

For the six month periods ended March 31,

 

 

 

 

2009 

 

2008 

Net revenues

$

1,001,100 

 

$

1,834,000 

Cost of revenues

691,800 

 

1,756,200 

 

 

 

Gross margin

309,300 

 

77,800 

Operating expenses:

 

 

 

 

Research and development

609,500 

 

722,800 

 

Selling, general and administrative

744,900 

 

813,300 

 

 

Total operating expenses

1,354,400 

 

1,536,100 

 

 

 

Operating loss

(1,045,100)

 

(1,458,300)

Other income and expense, net

 

 

 

 

Interest income

10,300 

 

33,700 

 

Interest expense

(1,900)

 

– 

 

Other expense

(4,100)

 

(129,900)

 

 

Other income and expense, net

4,300 

 

(96,200)

 

 

 

Loss before provision for income taxes

(1,040,800)

 

(1,554,500)

Provision for income taxes

900 

 

– 

 

 

 

Net loss

$

(1,041,700)

 

$

(1,554,500)

Basic and diluted loss per common share

$

(0.15)

 

$

(0.23)

Basic and diluted weighted average common shares outstanding

6,814,438 

 

6,814,188 

 

 

 

See accompanying Notes to Condensed Financial Statements.

 



Condensed Statements of Cash Flows

 

(unaudited)

 

 

 

 

 

 

For the six month periods ended March 31,

 

 

 

 

 

2009 

 

2008 

Cash flows from operating activities:

 

 

 

 

Net loss

$

(1,041,700)

 

$

(1,554,500)

 

Adjustments to reconcile net loss to net cash used in

 

 

 

 

 

operating activities:

 

 

 

 

 

Depreciation

161,200 

 

147,800 

 

 

Write-down of inventory

250,200 

 

1,120,600 

 

 

Deferred rent

8,500 

 

12,600 

 

 

Loss on disposal of capital equipment

4,100 

 

129,900 

 

 

Stock-based compensation

2,800 

 

8,600 

 

 

Changes in current assets and liabilities:

 

 

 

 

 

 

Accounts receivable

290,800 

 

(55,000)

 

 

 

Inventory

(6,200)

 

109,300 

 

 

 

Prepaid expenses and other current assets

18,900 

 

(120,700)

 

 

 

Accounts payable

(74,200)

 

78,600 

 

 

 

Accrued payroll and vacation

(21,100)

 

(100) 

 

 

 

Accrued commissions

(3,800)

 

(6,800)

 

 

 

Other accrued expenses

2,400 

 

(17,500)

 

 

 

 

Net cash used in operating activities

(408,100)

 

(147,200)

Cash flows from investing activities:

 

 

 

 

Purchases of available-for-sale securities

– 

 

(25,000)

 

Sales of available-for-sale securities

975,000 

 

112,000 

 

Capital expenditures

(120,300)

 

(201,000)

 

 

 

 

Net cash provided by investing activities

854,700 

 

(114,000)

Cash flows from financing activities:

 

 

 

 

Proceeds from bank borrowings

975,000 

 

– 

 

Repayment of bank borrowings

(975,000)

 

– 

 

Exercise of employee stock options

– 

 

1,900 

 

 

 

 

Net cash provided by financing activities

– 

 

1,900 

Net increase (decrease) in cash and cash equivalents

446,600 

 

(259,300)

Cash and cash equivalents, beginning

312,400 

 

884,000 

Cash and cash equivalents, ending

$

759,000

 

$

624,700 

 

 

 

 

See accompanying Notes to Condensed Financial Statements.

 



LOGIC Devices Incorporated

 

Notes to Condensed Financial Statements

 

(unaudited)

 

1.             Basis of Presentation

 

The accompanying unaudited interim financial statements reflect all adjustments that are, in the opinion of management, necessary to present fairly the financial position, results of operations, and cash flows of LOGIC Devices Incorporated (the Company) for the periods indicated.

 

The accompanying unaudited interim financial statements have been prepared in accordance with the instructions for Form 10-Q, and, therefore, do not include all information and footnotes necessary for a complete presentation of the financial position, results of operations, and cash flows for the Company, in conformity with accounting principles generally accepted in the United States of America. The Company has filed audited financial statements that include all information and footnotes necessary for such a presentation of the financial position, results of operations, and cash flows for the fiscal years ended September 30, 2008 and 2007, with the Securities and Exchange Commission. It is suggested that the accompanying unaudited interim financial statements be read in conjunction with the aforementioned audited financial statements. In the opinion of management, the unaudited interim financial statements reflect all adjustments (consisting of normal and recurring accruals) necessary to make the results of operations for the interim periods a fair statement of such operations. The results of operations for the interim period ended March 31, 2009 are not necessarily indicative of the results to be expected for the full fiscal year to end September 30, 2009.

 

2.             Inventories

 

A summary of inventories follows:

 

 

 

 

March 31,

 

September 30,

 

 

 

2009

 

2008

 

 

 

 

 

 

Raw materials

$

162,900 

 

$

156,500 

Work-in-process

143,100 

 

149,400 

Finished goods

874,700 

 

1,118,800 

 

 

 

$

1,180,700 

 

$

1,424,700 

 

3.             Investment in Available-for-Sale Securities and Bank Borrowings

 

Since May 2006, we have had approximately $1 million of auction rate securities (ARS) classified as a short-term investment in available-for-sale securities, which paid a monthly average of $3,500 of dividends and interest. Historically, these securities were considered cash alternatives that were risk averse and highly liquid. Beginning in February 2008, the auctions began to fail and no secondary market developed. Accordingly, ARS lacked liquidity and were no longer considered cash alternatives. While there was no current market for the ARS, the underlying issuers were required to pay the interest and dividends when due. On October 16, 2008, we elected to accept an offer from UBS Financial Services Inc. (UBS) to sell our ARS to UBS at par value at any time during a two-year period, beginning January 2, 2009. In addition, on November 10, 2008, we obtained a no net-cost line of credit from UBS Bank USA for the par value of our ARS. We drew down the entire $975,000 available balance on November 21, 2008. This loan was considered no net-cost as the interest charged was the lesser of the LIBOR rate plus an established percentage rate or the interest and/or dividends earned on our ARS. Therefore, our interest paid could be no more than the interest and/or dividends we earned on the ARS.

 



In December 2008, UBS liquidated $50,000 of our $975,000 of ARS, which we used to pay down the line of credit. In January 2009, the remaining $925,000 of ARS were liquidated and paid down against the line of credit. All UBS accounts were closed in February 2009.

 

4.             Shareholders’ Equity

 

The Company has issued and may issue common stock options to its employees, certain consultants, and its nonemployee board members. Effective January 1, 2006, the Company adopted FASB Statement No. 123 (revised 2004) (FAS 123(R)), Share-Based Payments. FAS 123(R) requires all entities to recognize compensation expense in an amount equal to the fair value of share-based payments, such as stock options granted to board members. The Company elected to apply FAS 123(R) with a modified prospective method. Under this method, the Company is required to record compensation expense for newly granted options and (as previous awards continue to vest) for the unvested portion of previously granted awards that remain outstanding at the date of adoption. Additionally, the financial statements for the interim periods and fiscal years prior to adoption of FAS 123(R) do not reflect any adjusted amounts. The Company recognized $2,800 in compensation expense for director stock options on March 11, 2009.

 

5.             Earnings Per Share

 

Basic earnings per share is calculated by dividing net income by the weighted average common shares outstanding during the period. Diluted earnings per share reflects the net incremental shares that would be issued if dilutive outstanding stock options were exercised, using the treasury stock method. In the case of a net loss, no incremental shares would be issued becase they are antidilutive. Stock options with exercise prices above the average market price during the period are also antidilutive.

 

There were 322,500 and 367,500 common stock options outstanding at March 31, 2009 and 2008, respectively. These options were not considered in calculating the diluted loss per share as their effect would have been antidilutive. As a result, for the quarter and six months ended March 31, 2009 and 2008, the Company’s basic and diluted losses per share are the same.

 

6.             Adoption of SFAS 157

 

In the first quarter of 2009, the Company adopted SFAS No. 157 for all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. SFAS No. 157 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions, and credit risk.

 

SFAS No. 157 also establishes a fair value hierarchy, which prioritizes the inputs to valuation techniques used to measure fair value into three levels. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is available and significant to the fair value measurement. SFAS No. 157 establishes and prioritizes three levels of inputs that may be used to measure fair value:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 – Inputs that are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.

 

The Company’s only financial asset covered by SFAS 157 was its investments in available-for-sale securities (see Note 3), which it categorized as Level 3.



Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Reported financial results may not be indicative of the financial results of future periods. All non-historical information contained in the following discussion constitutes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Words such as “anticipates, appears, expects, intends, hopes, plans, believes, seeks, estimates, may, will,” and variations of these words or similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and involve a number of risks and uncertainties, including but not limited to operating results, new product introductions and sales, competitive conditions, customer demand, capital expenditures and resources, manufacturing capacity utilization, and intellectual property claims and defense. Factors that could cause actual results to differ materially are included in, but not limited to, those identified in "Item 1A – Risk Factors" in the Annual Report on Form 10-K for our fiscal year ended September 30, 2008 and in the "Management's Discussion and Analysis of Financial Condition and Results of Operations" in such Annual Report on Form 10-K and in this Quarterly Report on Form 10-Q. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may reflect events or circumstances after the date of this report.

 

Results of Operations

 

Revenues

 

For the quarter and six months ended March 31, 2009, our net revenues decreased by $409,600 (42%) and $832,900 (45%) compared to the same periods of fiscal 2008. This decrease was primarily the result of the revenues from military projects decreasing and further deterioration of the revenue contributions from our older product offerings.

 

Expenses

 

Our cost of revenues for the quarter and six months ended March 31, 2009 decreased $737,000 (73%) and $1,064,400 (61%) compared to the same periods of fiscal 2008. This decrease is the result of the decrease in net revenues and a decrease in write-downs of inventory in fiscal 2009. During fiscal 2008, the Company wrote down $1,120,600 of slow-moving and/or obsolete inventory as of March 31, 2008, while in fiscal 2009, the inventory write-downs aggregate $250,200.

 

Research and development (R&D) expenditures for the quarter and six months ended March 31, 2009 decreased by $53,800 (15%) and $113,300 (16%) compared to the same periods of fiscal 2008. This decrease was the result of a reduction in staffing. As the development of new products is key to future growth, R&D expenses are expected to continue at the current level.

 

Selling, general, and administrative expenditures for the quarter and six months ended March 31, 2009 decreased by $10,100 (2%) and $68,400 (8%) compared to the same periods of fiscal 2008. This decrease was primarily the result of a reduction in staffing and a non-recurring severance charge in fiscal 2008.

 

For the quarter and six months ended March 31, 2009, interest income decreased by $15,200 (89%) and $23,400 (69%) compared to the same periods of fiscal 2008. This decrease is the result of lower cash balances and lower interest rates. Write-offs of capital equipment decreased in fiscal 2009 from $129,900 in fiscal 2008 to $4,100.

 

The decrease in net revenues for the quarter and six months ended March 31, 2009 was partially offset by the decrease in inventory write-downs and operating expenses, resulting in a decrease in the net loss for the quarter and six month periods of $370,900 (47%) and $512,800 (33%), respectively.

 

Liquidity and Capital Resources

 

Cash Flows

 

While the net loss for the six months ended March 31, 2009 was $1,041,700, the net cash used for operations was only $408,100. During the first six months of fiscal 2009, we wrote-off $250,200 of inventory, which increased the net loss but did not affect cash flows. Reductions of accounts receivable resulted in net cash inflows of $290,800 for operations. The liquidating of auction rate securities during January 2009 also resulted in an increase in net cash of $975,000, while the Company used $120,300 for the purchase of capital equipment to prepare for testing of new products.

 

Although we had a net loss of $1,544,500 for the six months ended March 31, 2008, we used net cash of only $147,200, primarily because the net loss includes write-offs of inventory totaling $1,120,200. The net cash used was largely the result of a increase in accounts receivable and the payment of prepaid expenditures, totaling $175,700. In addition, during the six months ended March 31, 2008, we used $201,000 for capital expenditures (mainly related to new product tooling) and made $112,000 from the sale of available-for-sale securities.

 

Working Capital

 

Historically, due to order scheduling by our customers, up to 80% of our quarterly revenues are shipped in the last month of the quarter, so a large portion of shipments included in our quarter-end accounts receivable are not yet due per our net 30 day terms. As a result, quarter-end accounts receivable balances are typically at their highest level for the respective period.

 

As a fabless semiconductor company with products having longer than normal product life cycles, our investment in inventories has been, and will continue to be, significant. Although high levels of inventory impact liquidity, we believe these costs are a less costly alternative to owning a wafer fabrication facility. Over the past few years, we have attempted to streamline our product offerings, in turn reducing our inventory levels, and we will continue this effort in the upcoming periods.

 

During fiscal 2008, we reduced our inventory by 67%, or $2,964,000, including write-downs of $2,059,300, and have reduced our inventory by an additional 17%, or $244,000, during the first six months of fiscal 2009. This reduction in fiscal 2009 includes a write-down of $250,200 for slow-moving inventory.

 

Financing

 

On November 10, 2008, we obtained a no net-cost line of credit from UBS Bank USA for the $975,000 par value of our Auction Rate Securities (ARS). We drew down the entire $975,000 available balance on November 21, 2008 so we would have the cash readily available rather than held in the illiquid ARS at UBS Financial Services Inc. (UBS). This loan was no net-cost as the interest charged was the lesser of the LIBOR rate plus an established percentage rate or the interest and/or dividends earned on our ARS. Therefore, our interest paid can be no more than the interest and/or dividends we earn on the ARS. In addition, on October 16, 2008, we signed an agreement with UBS to sell our ARS to UBS at par value within a two-year period beginning January 2, 2009.

 

At the time these ARS Rights were exercised, we planned to pay back the no net-cost loan from UBS Bank USA and the line would be closed. In December 2008, UBS liquidated $50,000 of our $975,000 of ARS, which we used to pay down the line of credit. In January 2009, the remaining $925,000 of ARS were liquidated and paid down against the line of credit and all UBS accounts were closed in February 2009.

 

We believe the cost reductions we have undertaken in the past few years will allow us to use this cash, along with cash from future revenues, to fund current operations and future capital needs. However, we continue to evaluate our debt and equity financing opportunities.

 

Impact of New Financial Accounting Standards

 

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities Including an Amendment of FASB Statement No. 115. SFAS No. 159 permits entities to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value. This statement also establishes presentation and disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar types of assets and liabilities. SFAS No. 159 became effective on October 1, 2008 for us and we did not elect to adopt the fair value option for any financial instruments.



In May 2008, the FASB issued SFAS No.162, The Hierarchy of Generally Accepted Accounting Principles. SFAS 162 identifies the sources of accounting principles and the framework for selecting the principles to be used in the preparation of financial statements of nongovernmental entities that are presented in conformity with GAAP. SFAS 162 will become effective 60 days following the SEC’s approval of the Public Company Accounting Oversight Board amendments to AU Section 411, The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles. SFAS No. 162 is effective for fiscal years beginning after November 15, 2008. We are currently assessing the impact, if any, SFAS 162 will have on our financial statements.

 

Item 3.  Quantitative and Qualitative Disclosures about Market Risk

 

We conduct all of our transactions, including those with foreign suppliers and customers, in U.S. dollars. We are therefore not directly subject to the risks of foreign currency fluctuations and do not hedge or otherwise deal in currency instruments in an attempt to minimize such risks. Demand from foreign customers and the ability or willingness of foreign suppliers to perform their obligations to us may be affected by the relative change in value of such customer or supplier's domestic currency to the value of the U.S. dollar. Furthermore, changes in the relative value of the U.S. dollar may change the price of our products relative to the prices of our foreign competitors.

 

Item 4.  Controls and Procedures

 

Based upon an evaluation as of March 31, 2009, our President and Chief Financial Officer concluded that our disclosure controls and procedures are effective. There have been no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2009 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

Part II – OTHER INFORMATION

 

Item 1.  Legal Proceedings

 

From time to time, we receive demands from various parties asserting patent or other claims in the ordinary course of business. These demands are often not based on any specific knowledge of our products or operations. Because of the uncertainties inherent in litigation, the outcome of any such claim, including simply the cost of a successful defense against such a claim, could have a material adverse impact on us.

 

Item 1A.  Risk Factors

 

There are no other material changes to the risk factors disclosed in our Form 10-K filed with SEC on December 19, 2008 for the fiscal year ended September 30, 2008.

 

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

 

Not applicable.

 

Item 3.  Defaults Upon Senior Securities

 

Not applicable.

 

Item 4.  Submission of Matters to a Vote of Security Holders

 

At 9:00 a.m. on March 11, 2009, the Company held its Annual Meeting of Shareholders at its headquarters, located at 1375 Geneva Drive, Sunnyvale, California 94089. There were 6,598,327 shares present or represented by proxy at the meeting, representing a quorum.

 

The one item of business was the election of directors. Shareholders are permitted to vote cumulatively in the election of directors, which allows each shareholder to cast a number of votes equal to the number of directors to be elected multiplied y the number of shares owned, and to distribute such votes among the candidates in such a proportion as such shareholder may determine. In order to vote cumulatively, a shareholder must give notice of this intention by proxy or at the meeting. The votes for each nominee, listed alphabetically by last name, are as set forth in the following table:

 

 

FOR

 

WITHHELD

 

 

 

 

Brian P. Cardozo

5,508,856

 

1,089,471

Howard L. Farkas

5,506,125

 

1,092,202

Steven R. Settles

5,518,066

 

1,080,261

William J. Volz

6,239,828

 

358,499

 

As a result of the vote, all nominees were elected as directors at the meeting.

 

Item 5.  Other Information

 

Not applicable.

 

Item 6.  Exhibits

 

The Index to Exhibits appears at Page 14 of this report on Form 10-Q.



SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

LOGIC Devices Incorporated

(Registrant)

 

 

 

Date: May 1, 2009

By:  /s/ William J. Volz    

William J. Volz

President and Chief Executive Officer

(Principal Executive Officer)

 

 

 

Date: May 1, 2009

By:  /s/ Kimiko Milheim   

Kimiko Milheim

Chief Financial Officer

(Principal Finance and Accounting Officer)

 



INDEX TO EXHIBITS

 

 

Exhibit No.

 

Description

 

 

 

 

3.1

 

 

Articles of Incorporation, as amended in 1988. [3.1] (1)92

3.2

 

 

Bylaws, as amended and restated effective March 8, 2007. [3.2] (2)

10.1

 

 

Real Estate lease regarding Registrant's Sunnyvale, California facilities. [99.1] (3)

10.2

 

 

Amended and Restated LOGIC Devices Incorporated 1998 Director Stock Incentive Plan, as amended.

10.3

 

 

LOGIC Devices Incorporated 2007 Employee Stock Incentive Plan.

10.4

 

 

Registration Rights Agreement dated October 3, 1998 between William J. Volz, BRT Partnership, and Registrant. [10.19] (4)

31.1

 

 

Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14 and 15d-14.

31.2

 

 

Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14 and 15d-14.

32.1

 

 

Certifications of Principal Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350.

 

 

 

 

 

 

 

 

[  ]

 

 

Exhibits so marked have been previously filed with the Securities and Exchange Commission (SEC) as exhibits to the filings shown below under the exhibit numbers indicated following the respective document description and are incorporated herein by reference.

 

(1)

 

 

Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2004, as filed with the SEC on January 26, 2005.

 

(2)

 

 

Quarterly Report on Form 10-Q for the quarter ended March 31, 2007, as filed with the SEC on May 15, 2007.

 

(3)

 

 

Current Report on Form 8-K, as filed with the SEC on August 7, 2007.

 

(4)

 

 

Annual Report on Form 10-K for the transition period from January 1, 1998 to September 30, 1998, as filed with the SEC on January 13, 1999.